Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma: Cochrane systematic review

Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma: Cochrane systematic review is a topic covered in the Cochrane Abstracts.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma: Cochrane systematic review ID - 431293 BT - Cochrane Abstracts UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431293/all/Regular_treatment_with_long_acting_beta_agonists_versus_daily_regular_treatment_with_short_acting_beta_agonists_in_adults_and_children_with_stable_asthma:_Cochrane_systematic_review DB - Evidence Central DP - Unbound Medicine ER -